Sodium Polystyrene Sulfonate
NDC 46287-012, Sodium Polystyrene Sulfonate, powder, for suspension, from CMP Pharma, Inc..
- Product NDC
- 46287-012
- Status
- Listed
- Labeler
- CMP Pharma, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL, RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA089910
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/46287-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM POLYSTYRENE SULFONATE1 g/g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 46287-012-16 | 46287001216 | 454 g in 1 JAR (46287-012-16) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2017bfbe-cda8-46f1-b4f1-9c086c3249a9NADAC price for package 46287001216
GET /v1/drugs/nadac/46287001216
Use it
Look up 46287-012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/46287-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 46287-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.